Funders › MO › Pkd Foundation › 2019
Grants paid by Pkd Foundation, tax year 2019
EIN 43-1266906 · Kansas City, MO · Form 990, Schedule I
In tax year 2019, Pkd Foundation (EIN 43-1266906) reported 58 grants paid totaling $4,180,000. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2019
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2019 | Medical University of South Carolina Charleston, SC | A | $80,000 | paid | EFFECTS OF DIETARY SALT RESTRICTION ON CYSTOGENESIS IN ARPKD | 202100299349300905 |
| 2019 | University of Maryland Baltimore, MD | A | $80,000 | paid | POLYCYSTIN-1 CLEAVAGE PRODUCT P100: DISTINCTIVE TOPOLOGY, SPECIFIC PROPERTIES, AND POLYCYSTIN-2-ASSOCIATED CHANNEL ACTIVITY | 202100299349300905 |
| 2019 | Regents of the University of California Los Angeles, CA | A | $80,000 | paid | UNDERSTANDING HOW THE CILIARY TRANSITION ZONE CONTROLS POLYCYSTIN-2 LOCALIZATION TO CILIA | 202040809349300009 |
| 2019 | Mayo Clinic Minneapolis, MN | A | $80,000 | paid | THE ROLES OF DNA METHYLATION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE | 202040809349300009 |
| 2019 | University of Maryland Baltimore Baltimore, MD | A | $80,000 | paid | DISRUPTION OF THE APICAL JUNCTIONAL COMPLEX IN CYSTOGENESIS AND ADPKD | 202040809349300009 |
| 2019 | President and Fellows of Harvard College Boston, MA | A | $80,000 | paid | TAKING PKD OUT OF THE KIDNEY: DISSECTION OF POLYCYSTIN SIGNALING IN A NOVEL CELL-BASED SYSTEM | 202040809349300009 |
| 2019 | Yale University New Haven, CT | A | $80,000 | paid | GENETIC APPROACH TO DEFINE MEDIATORS OF POLYCYSTIN-1 FUNCTION IN POLYCYSTIC KIDNEY DISEASE | 202040809349300009 |
| 2019 | University of Maryland Baltimore, MD | A | $80,000 | paid | POLYCYSTIN-1 CLEAVAGE PRODUCT P100: DISTINCTIVE TOPOLOGY, SPECIFIC PROPERTIES, AND POLYCYSTIN-2-ASSOCIATED CHANNEL ACTIVITY | 202040809349300009 |
| 2019 | University of Alabama at Birmingham Birmingham, AL | A | $80,000 | paid | KIDNEY SPECIFIC DRUG DELIVERY USING NANOPARTICLES IN PKD1 MICE | 202040809349300009 |
| 2019 | Northwestern University - Asrsp Cash Management Evanston, IL | A | $80,000 | paid | THE MOLECULAR AND MECHANISTIC IMPACTS OF FINGER 1 VARIANTS ON PKD2 ION CHANNEL FUNCTION IN THE PRIMARY CILIA. | 202100299349300905 |
| 2019 | Yale University Glastonbury, CT | A | $80,000 | paid | CONTROLLING THE VIABILITY OF PKD MUTANT CELLS VIA INACTIVATION OF XBP1 AS A NOVEL STRATEGY TO TREAT ADPKD | 202100299349300905 |
| 2019 | Yale University Glastonbury, CT | A | $80,000 | paid | CONTROLLING THE VIABILITY OF PKD MUTANT CELLS VIA INACTIVATION OF XBP1 AS A NOVEL STRATEGY TO TREAT ADPKD | 202040809349300009 |
| 2019 | St John's University Queens, NY | A | $80,000 | paid | THE ROLE OF POLYCYSTIN-1 IN THE POLYCYSTIN-1/POLYCYSTIN-2 ION CHANNEL COMPLEX | 202100299349300905 |
| 2019 | Brigham and Women's Hospital Boston, MA | A | $80,000 | paid | ELUCIDATING THE CYSTOGENIC PROTEOME IN POLYCYSTIC KIDNEY DISEASE | 202040809349300009 |
| 2019 | University of Alabama at Birmingham Birmingham, AL | A | $80,000 | paid | KIDNEY SPECIFIC DRUG DELIVERY USING NANOPARTICLES IN PKD1 MICE | 202100299349300905 |
| 2019 | Northwestern University - Asrsp Cash Management Evanston, IL | A | $80,000 | paid | THE MOLECULAR AND MECHANISTIC IMPACTS OF FINGER 1 VARIANTS ON PKD2 ION CHANNEL FUNCTION IN THE PRIMARY CILIA. | 202040809349300009 |
| 2019 | Yale University New Haven, CT | A | $80,000 | paid | ROLE OF INTERSTITIAL CELLS IN RENAL CYSTOGENESIS | 202040809349300009 |
| 2019 | University of Maryland Baltimore Baltimore, MD | A | $80,000 | paid | DISRUPTION OF THE APICAL JUNCTIONAL COMPLEX IN CYSTOGENESIS AND ADPKD | 202100299349300905 |
| 2019 | St John's University Queens, NY | A | $80,000 | paid | THE ROLE OF POLYCYSTIN-1 IN THE POLYCYSTIN-1/POLYCYSTIN-2 ION CHANNEL COMPLEX | 202040809349300009 |
| 2019 | Cleveland Clinic Foundation Cleveland, OH | A | $80,000 | paid | REGULATION OF CILIARY G-PROTEIN SIGNALING BY POLYCYSTIN-1 | 202100299349300905 |
| 2019 | Mayo Clinic Minneapolis, MN | A | $80,000 | paid | THE ROLES OF DNA METHYLATION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE | 202100299349300905 |
| 2019 | Univ of Ks Medical Center Research Institute Inc Kansas City, KS | A | $80,000 | paid | MECHANISM OF POLYCYSTIN-1-REGULATED G PROTEIN SIGNALING AND ITS ROLE IN THE PATHOGENESIS AND TREATMENT OF PKD | 202100299349300905 |
| 2019 | University of Kansas Medical School Kansas City, MO | A | $80,000 | paid | PRE-CLINICAL EVALUATION OF CASPASE 1 AS A THERAPEUTIC TARGET IN ADPKD. | 202040809349300009 |
| 2019 | Brigham and Women's Hospital Boston, MA | A | $80,000 | paid | ELUCIDATING THE CYSTOGENIC PROTEOME IN POLYCYSTIC KIDNEY DISEASE | 202100299349300905 |
| 2019 | Regents of University of Colorado Denver, CO | A | $80,000 | paid | UNDERSTANDING THE ROLE OF CD8+ T-CELLS IN HALTING RENAL CYSTOGENESIS | 202040809349300009 |
| 2019 | University of Maryland School of Medicine Baltimore, MD | A | $80,000 | paid | BAC TRANSGENESIS TO MODEL AN ANEURYSM-ASSOCIATED HUMAN MUTATION IN MICE | 202100299349300905 |
| 2019 | The Children's Mercy Hospital Kansas City, MO | A | $80,000 | paid | MOLECULAR CHARACTERIZATION OF CYST FORMATION IN A PORCINE MODEL OF EARLY ADPKD | 202100299349300905 |
| 2019 | Yale University New Haven, CT | A | $80,000 | paid | GENETIC APPROACH TO DEFINE MEDIATORS OF POLYCYSTIN-1 FUNCTION IN POLYCYSTIC KIDNEY DISEASE | 202100299349300905 |
| 2019 | The Children's Mercy Hospital Kansas City, MO | A | $80,000 | paid | MOLECULAR CHARACTERIZATION OF CYST FORMATION IN A PORCINE MODEL OF EARLY ADPKD | 202040809349300009 |
| 2019 | Regents of the University of California Los Angeles, CA | A | $80,000 | paid | UNDERSTANDING HOW THE CILIARY TRANSITION ZONE CONTROLS POLYCYSTIN-2 LOCALIZATION TO CILIA | 202100299349300905 |
| 2019 | University of Maryland School of Medicine Baltimore, MD | A | $80,000 | paid | BAC TRANSGENESIS TO MODEL AN ANEURYSM-ASSOCIATED HUMAN MUTATION IN MICE | 202040809349300009 |
| 2019 | Cleveland Clinic Foundation Cleveland, OH | A | $80,000 | paid | REGULATION OF CILIARY G-PROTEIN SIGNALING BY POLYCYSTIN-1 | 202040809349300009 |
| 2019 | President and Fellows of Harvard College Boston, MA | A | $80,000 | paid | TAKING PKD OUT OF THE KIDNEY: DISSECTION OF POLYCYSTIN SIGNALING IN A NOVEL CELL-BASED SYSTEM | 202100299349300905 |
| 2019 | Johns Hopkins University Baltimore, MD | A | $80,000 | paid | SMALL MOLECULE CORRECTORS REDUCE CYST GROWTH IN ADPKD | 202040809349300009 |
| 2019 | Regents of University of Colorado Denver, CO | A | $80,000 | paid | UNDERSTANDING THE ROLE OF CD8+ T-CELLS IN HALTING RENAL CYSTOGENESIS | 202100299349300905 |
| 2019 | Yale University New Haven, CT | A | $80,000 | paid | ROLE OF INTERSTITIAL CELLS IN RENAL CYSTOGENESIS | 202100299349300905 |
| 2019 | Medical University of South Carolina Charleston, SC | A | $80,000 | paid | EFFECTS OF DIETARY SALT RESTRICTION ON CYSTOGENESIS IN ARPKD | 202040809349300009 |
| 2019 | Johns Hopkins University Baltimore, MD | A | $80,000 | paid | SMALL MOLECULE CORRECTORS REDUCE CYST GROWTH IN ADPKD | 202100299349300905 |
| 2019 | University of Kansas Medical School Kansas City, MO | A | $80,000 | paid | PRE-CLINICAL EVALUATION OF CASPASE 1 AS A THERAPEUTIC TARGET IN ADPKD. | 202100299349300905 |
| 2019 | Univ of Ks Medical Center Research Institute Inc Kansas City, KS | A | $80,000 | paid | MECHANISM OF POLYCYSTIN-1-REGULATED G PROTEIN SIGNALING AND ITS ROLE IN THE PATHOGENESIS AND TREATMENT OF PKD | 202040809349300009 |
| 2019 | University of Maryland Baltimore, MD | A | $60,000 | paid | RELIEVING THE STRESS OF PKD: A NEW ROLE OF PKHD1 IN DETOXIFICATION MEDIATED VIA DIFFERENTIAL CLEAVAGE OF THE INTRACELLULAR DOMAIN | 202040809349300009 |
| 2019 | Mayo Clinic Minneapolis, MN | A | $60,000 | paid | RESTORING CILIARY LEVEL OF FUNCTIONAL POLYCYSTINS AS A NOVEL THERAPEUTIC APPROACH FOR ADPKD TREATMENT | 202040809349300009 |
| 2019 | Ut Southwestern Medical Center Dallas, TX | A | $60,000 | paid | ROLE OF TULP3-MEDIATED CILIARY PROTEIN TRAFFICKING IN KIDNEY CYSTOGENESIS | 202100299349300905 |
| 2019 | Yale University New Haven, CT | A | $60,000 | paid | TARGETING THE CELL CYCLE AS A POTENTIAL TREATMENT FOR ADPKD: THE ROLE OF CYCLIN-DEPENDENT KINASE 1 | 202100299349300905 |
| 2019 | University of Texas Southwestern Medical Center Irving, TX | A | $60,000 | paid | INVESTIGATING THE M6A RNA METHYLATION PATHWAY AS A THERAPEUTIC OPTION FOR ADPKD TREATMENT | 202100299349300905 |
| 2019 | University of Texas Southwestern Medical Center Irving, TX | A | $60,000 | paid | INVESTIGATING THE M6A RNA METHYLATION PATHWAY AS A THERAPEUTIC OPTION FOR ADPKD TREATMENT | 202040809349300009 |
| 2019 | Ut Southwestern Medical Center Dallas, TX | A | $60,000 | paid | ROLE OF TULP3-MEDIATED CILIARY PROTEIN TRAFFICKING IN KIDNEY CYSTOGENESIS | 202040809349300009 |
| 2019 | Yale University New Haven, CT | A | $60,000 | paid | TARGETING THE CELL CYCLE AS A POTENTIAL TREATMENT FOR ADPKD: THE ROLE OF CYCLIN-DEPENDENT KINASE 1 | 202040809349300009 |
| 2019 | Mayo Clinic Minneapolis, MN | A | $60,000 | paid | RESTORING CILIARY LEVEL OF FUNCTIONAL POLYCYSTINS AS A NOVEL THERAPEUTIC APPROACH FOR ADPKD TREATMENT | 202100299349300905 |
| 2019 | University of Maryland Baltimore, MD | A | $60,000 | paid | RELIEVING THE STRESS OF PKD: A NEW ROLE OF PKHD1 IN DETOXIFICATION MEDIATED VIA DIFFERENTIAL CLEAVAGE OF THE INTRACELLULAR DOMAIN | 202100299349300905 |
| 2019 | University of Colorado Denver, CO | A | $50,000 | paid | PKD GENE THERAPY TARGETING THE 4E-BP1 PATHWAY | 202040809349300009 |
| 2019 | University of Colorado Denver, CO | A | $50,000 | paid | PKD GENE THERAPY TARGETING THE 4E-BP1 PATHWAY | 202100299349300905 |
| 2019 | Kumc Kidney Institute Fairway, KS | A | $50,000 | paid | TARGETING THE LKB1-AMPK SIGNALING PATHWAY IN POLYCYSTIC KIDNEY DISEASE | 202100299349300905 |
| 2019 | Yale University New Haven, CT | A | $50,000 | paid | GENETIC VARIANTS PREDISPOSING TO INTRACRANIAL ANEURYSM FORMATION IN ADPKD | 202100299349300905 |
| 2019 | Kumc Kidney Institute Fairway, KS | A | $50,000 | paid | TARGETING THE LKB1-AMPK SIGNALING PATHWAY IN POLYCYSTIC KIDNEY DISEASE | 202040809349300009 |
| 2019 | Yale University New Haven, CT | A | $50,000 | paid | GENETIC VARIANTS PREDISPOSING TO INTRACRANIAL ANEURYSM FORMATION IN ADPKD | 202040809349300009 |
| 2019 | Mayo Clinic Minneapolis, MN | A | $40,000 | paid | ADPKD MUTATION DATABASE | 202040809349300009 |
| 2019 | Mayo Clinic Minneapolis, MN | A | $40,000 | paid | ADPKD MUTATION DATABASE | 202100299349300905 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.